For providers

ICS Cuts Exacerbations About 55%

November 12, 2026

Editorial illustration for the article "ICS Cuts Exacerbations About 55%"

A clinical brief for referring providers — week 4 of a 4-part series on asthma exacerbations.

A question before the clinical note: How many rescue-inhaler canisters per year is associated with increased exacerbation and mortality risk?

a) Three or more for exacerbation risk; twelve or more for mortality risk b) Six or more for both c) Twelve or more for both

Dr. {{first_name}},

One number carries the argument: inhaled corticosteroid treatment reduces clinically relevant exacerbations by roughly 55% versus placebo or a rescue inhaler alone.

Prevention is not about better rescue medicine. It is about treating the inflammation between the attacks.

55% fewer clinically relevant exacerbations with inhaled corticosteroid treatment versus placebo or rescue inhaler alone (Sin et al., JAMA, 2004).

Rescue-inhaler-only treatment is no longer recommended. A patient collecting a canister a month is telling you something before they ever present acutely.

Also well supported (GINA 2026)

Guided self-management with a written action plan

Smoking and vaping cessation

Immunizations

Treating allergic rhinitis, sinusitis, reflux, obesity and obstructive sleep apnea

Confirmed food allergy management

Specialist referral for severe asthma

Worth referring

Repeated acute presentations or any hospitalization

Frequent or maintenance OCS

Rescue inhaler overuse at the thresholds above

Difficulty confirming the diagnosis

Symptoms suggesting an infective, cardiac or bronchiectatic cause

Significant multimorbidity

Specialist follow-up after an acute presentation is associated with fewer subsequent ED visits and hospitalizations (GINA 2026). That is the honest case — not that we do something you cannot, but that the follow-through is what reliably falls through the cracks.

When you refer: full pulmonary evaluation, diagnosis confirmed, technique and adherence assessed properly, comorbidities treated, a controller regimen and written action plan built. Where severe asthma is confirmed, phenotyping and biologic evaluation follow. You get a findings note back.

Refer your toughest asthma patient

Send us the patient who keeps coming back, the one on their third canister this year, or the one you cannot get a clean diagnosis on.

Call (847) 860-7250.

Sources: Sin et al., JAMA, 2004; Kew et al., Cochrane, 2022; Reddel et al., GINA 2026.

The answer

Three or more canisters a year raises exacerbation risk; twelve or more raises the risk of death from asthma (Kew et al., Cochrane, 2022).